Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AseraCare is a U.S. healthcare services company focused primarily on hospice and related home-based care rather than drug development. The business has provided hospice, palliative, and home health services for patients with serious or terminal illness across multiple states. AseraCare was acquired by Amedisys in June 2020 as part of Amedisys' expansion in hospice care. It appears to continue as an operating brand or acquired business within a larger post-acute care network rather than as an independent biotech or pharma company. For a biotech analyst, this is a healthcare delivery organization with commercial service operations, not a therapeutic pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AseraCare.